Emergen logo.png
Global Targeted Therapeutics Market Size to Reach USD 214.31 Billion in 2032 | Emergen Research
October 16, 2023 09:09 ET | Emergen Research
Vancouver, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Current Market Scenario (Market estimates) The global Targeted Therapeutics Market size was USD 93.75 Billion in 2020. Increasing prevalence of cancer,...
Transparency Market Research
Acute Lymphoblastic Leukemia Market to Surpass USD 4.5 billion with CAGR 7.6% by 2031,TMR Report
October 05, 2023 07:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute lymphoblastic leukemia market was estimated to have acquired US$ 2.2 billion in...
Global Leukapheresis Market
Leukapheresis Market Research Report 2023 - Global Opportunity/Analysis to 2028
September 25, 2023 10:33 ET | Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma),...
Emergen logo.png
Global Minimal Residual Disease (MRD) Market Size to Reach USD 4,138.5 Million in 2030 | Emergen Research
September 14, 2023 09:51 ET | Emergen Research
Vancouver, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the...
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
August 01, 2023 08:00 ET | Vor Biopharma
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow...
Aptose Biosciences Inc. logo
Aptose Presents Highlights from Clinical Update
June 10, 2023 12:00 ET | Aptose Biosciences, Inc.
Finalized Dose Escalation/Dose Exploration Trial in 77 R/R AML PatientsFavorable safety with monotherapy responses across four dose levels with no DLT in mutationally diverse and difficult to treat...
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
May 11, 2023 16:05 ET | Vor Biopharma
VBP101 clinical data update planned at European Hematology Association (EHA) 2023VCAR33ALLO IND submission on-track for 1H 2023 CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:...
Gift of Life Marrow Registry
Woman Finally Meets Stem Cell Donor Who Saved Her Life
May 10, 2023 11:07 ET | Gift of Life Marrow Registry
BOCA RATON, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Two strangers, who are now deeply connected through a lifesaving blood stem cell transplant, met for the first time at Gift of Life Marrow...
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market to Grow by $1.65 Billion During 2023-2027
March 15, 2023 08:13 ET | Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The BCL-2 (B-cell Lymphoma...
Cancer Biomarkers Market to Accrue $34.85 Billion, by 2028 - Global Analysis by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer)
March 09, 2023 08:35 ET | The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, "Cancer Biomarkers Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...